Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)

Swedberg, Karl; Cleland, John G.F.; Dargie, Henry J.; Drexler, Helmut; Folláth, Ferenc; Komajda, Michel; Tavazzi, Luigi; Smiseth, Otto A.; Gavazzi, Antonello; Haverich, Axel; Hoes, Arno W.; Jaarsma, Tiny; Korewicki, J; Lévy, Samuel; Linde, Cecilia; López‐Sendón, José‐Luis; Nieminen, Markku S.; Piérard, Luc; Remme, Willem J.

doi:10.1093/eurheartj/ehi204

Cited by 1,796 publications

(348 citation statements)

References 171 publications

Supporting

Mentioning

312

Contrasting

Unclassified

Order By: Relevance

“…The inclusion criteria were as follows: chronic HF diagnosed according to the European Society of Cardiology (ESC) guidelines24 ≤12 weeks before enrollment; moderate to severe left ventricular systolic dysfunction (LVEF ≤45% by an imaging method such as echocardiography, radionuclide angiography, left ventriculography, or cardiac magnetic resonance imaging) documented <12 weeks before enrollment; NYHA class III or IV at the time of inclusion, or NYHA class II with ≥1 hospitalization for HF in the past 12 months; patient able to fully understand study information and give written informed consent. Patients were excluded if they had any of the following: current use of positive airway pressure therapy; life expectancy <1 year for diseases unrelated to chronic HF‐REF; cardiac surgery, percutaneous coronary intervention, myocardial infarction, or unstable angina within 6 months before randomization; cardiac resynchronization therapy implantation scheduled or performed within 6 months before randomization; transient ischemic attack or stroke within 3 months before enrollment; primary hemodynamically significant uncorrected valvular heart disease (obstructive or regurgitant) or any valvular disease expected to require surgery; acute myocarditis/pericarditis within 6 months before enrollment.…”

Section: Methodsmentioning

confidence: 99%

Phenotyping of Sleep‐Disordered Breathing in Patients With Chronic Heart Failure With Reduced Ejection Fraction—the SchlaHF Registry

Arzt

Oldenburg

Graml

et al. 2017

JAHA

View full text Add to dashboard Cite

BackgroundDifferent sleep‐disordered breathing (SDB) phenotypes, including coexisting obstructive and central sleep apnea (OSA‐CSA), have not yet been characterized in a large sample of patients with heart failure and reduced ejection fraction (HFrEF) receiving guideline‐based therapies. Therefore, the aim of the present study was to determine the proportion of OSA, CSA, and OSA‐CSA, as well as periodic breathing, in HFrEF patients with SDB.Methods and ResultsThe German SchlaHF registry enrolled patients with HFrEF receiving guideline‐based therapies, who underwent portable SDB monitoring. Polysomnography (n=2365) was performed in patients with suspected SDB. Type of SDB (OSA, CSA, or OSA‐CSA), the occurrence of periodic breathing (proportion of Cheyne‐Stokes respiration ≥20%), and blood gases were determined in 1557 HFrEF patients with confirmed SDB. OSA, OSA‐CSA, and CSA were found in 29%, 40%, and 31% of patients, respectively; 41% showed periodic breathing. Characteristics differed significantly among SDB groups and in those with versus without periodic breathing. There was a relationship between greater proportions of CSA and the presence of periodic breathing. Risk factors for having CSA rather than OSA were male sex, older age, presence of atrial fibrillation, lower ejection fraction, and lower awake carbon dioxide pressure (pco 2). Periodic breathing was more likely in men, patients with atrial fibrillation, older patients, and as left ventricular ejection fraction and awake pco 2 decreased, and less likely as body mass index increased and minimum oxygen saturation decreased.ConclusionsSchlaHF data show that there is wide interindividual variability in the SDB phenotype of HFrEF patients, suggesting that individualized management is appropriate.Clinical Trial Registration URL: https://www.clinicaltrials.gov/. Unique identifier: NCT01500759.

show abstract

Section: Methodsmentioning

confidence: 99%

Phenotyping of Sleep‐Disordered Breathing in Patients With Chronic Heart Failure With Reduced Ejection Fraction—the SchlaHF Registry

Arzt

Oldenburg

Graml

et al. 2017

JAHA

View full text Add to dashboard Cite

show abstract

“…Measurements used for left ventricular calculations were obtained based on the Guidelines of the European Society of Echocardiography 21. The E‐wave‐peak (early filling), A‐wave‐peak (atrial filling), and the ratio between the two were then determined.…”

Section: Methodsmentioning

confidence: 99%

Clinical characteristics of asymptomatic left ventricular diastolic dysfunction and its association with self‐rated health and N‐terminal B‐type natriuretic peptide: a cross‐sectional study

et al. 2016

View full text Add to dashboard Cite

AimsLeft ventricular hypertrophy, obesity, hypertension, and N‐terminal B‐type natriuretic peptide (Nt‐proBNP) predict left ventricular diastolic dysfunction with preserved systolic function (DD‐PSF). Self‐rated health (SRH) is shown to be associated with chronic diseases, but the association of SRH with DD‐PSF is unclear. In light of the clinical implications of DD‐PSF, the following goals are of considerable importance: (1) to determine the role of SRH in patients with DD‐PSF in the general population and (2) to study the association between Nt‐proBNP and DD‐PSF.Methods and resultsThe current study is a cross‐sectional study conducted on a random sampling of a rural population. Individuals 30–75 years of age were consecutively subjected to conventional echocardiography and tissue velocity imaging. Data were collected on 500 (48%) men and 538 (52%) women (n = 1038). DD‐PSF was the main outcome, and SRH and Nt‐proBNP were the primary indicators. Diabetes mellitus, hypertension, and obesity were accounted for as major confounders of the association with SRH. DD‐PSF was identified in 137 individuals, namely, 79 men (15.8%) and 58 women (10.8%). In a multivariate regression model, SRH (OR 2.95; 95% CI 1.02–8.57) and Nt‐proBNP (quartile 4 vs. quartile 1 OR 4.23; 95% CI 1.74–10.26) were both independently associated with DD‐PSF.ConclusionsSRH, evaluated based on a descriptive question on general health, should be included in the diagnostic process of DD‐PSF. In agreement with previous studies, our study confirms that Nt‐proBNP is a major indicator of DD‐PSF.

show abstract

“…Exercise program (EP) has been accepted as an important part of management of heart failure (HF) patients, because it demonstrated various beneficial effects [1,2]. However, recommendations or studies were usually directed towards chronic patients with HF who were already in optimal medical treatment and clinically stable [3][4][5].…”

Section: Introductionmentioning

confidence: 99%

Early Exercise Program for Patients with Heart Failure after Hospital Discharge

Radi¹,

Santoso²,

Siswanto³

et al. 2017

Int J Phys Med Rehabil

View full text Add to dashboard Cite

show abstract

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)

Abstract: Los comentarios-anotaciones ( * ) incluidos en esta traducción de las Guías han sido realizados por la Dra. Eulalia Roig (Barcelona, España).

Cited by 1,796 publications

References 171 publications

Phenotyping of Sleep‐Disordered Breathing in Patients With Chronic Heart Failure With Reduced Ejection Fraction—the SchlaHF Registry

Phenotyping of Sleep‐Disordered Breathing in Patients With Chronic Heart Failure With Reduced Ejection Fraction—the SchlaHF Registry

Clinical characteristics of asymptomatic left ventricular diastolic dysfunction and its association with self‐rated health and N‐terminal B‐type natriuretic peptide: a cross‐sectional study

Early Exercise Program for Patients with Heart Failure after Hospital Discharge

Contact Info

Product

Resources

About